What is the TVTX stock price prediction for next 2 weeks?

According to our price prediction algorithm,Travere Therapeutics, Inc. (TVTX) price will be around $63.45 in the next 2 weeks. This means it will decrease by -1.9862527031201702 from the last closing price. This prediction may vary from other time period filters for TVTX stock.

What can be the highest Possible price of TVTX stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, TVTX can achieve the highest price of $65.00 which is 0.40398346217980624 higher than last closing price. This prediction may vary from other time period filters for TVTX stock.

What can be the lowest Possible price of TVTX stock in next 2 weeks?

As per the forecast and algorithmic analysis, TVTX stock price can be as low as $61.86 which is -4.452711774738681 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for TVTX stock.

Will TVTX stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that TVTX stock will lose-1.9862527031201702 in the next 2 weeks. This prediction may vary from other time period filters for TVTX stock.

What is TVTX stock last closing price?

Last closing price of TVTX stock was $62.76.

What is TVTX stock price prediction?

TVTX stock price prediction means predicting the future closing prices of TVTX stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of TVTX stock in a certain time period.

How we predict TVTX stock future prices?

If you are searching for TVTX stock forecast, analysis or price prediction, then you might be wondering what Travere Therapeutics, Inc. (TVTX) will do in the future. Our TVTX price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This TVTX price prediction will likely answer most of your questions.

How frequent we update TVTX stock predictions?

We are updating the forecasts for the TVTX stock on daily basis.

Is using ML forecasting for TVTX stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for TVTX stock same for all the time periods?

No, the prediction for TVTX stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Travere Therapeutics, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$62.76-3.86%Since 2 Weeks

Predicted Price$63.45-1.99%For 2 Weeks

Upper Predicted Price$65.000.4%For 2 Weeks

Lower Predicted Price$61.86-4.45%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of TVTX will decline by -1.99% over the next 2 Weeks and hit $63.45 by Thursday, October 1, 2026. In that time frame, TVTX's share price is expected to range between $61.86 and $65.00.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Oct 1, 2026	61.86	63.45	65.00
Sep 30, 2026	62.17	63.73	65.36
Sep 29, 2026	60.05	61.61	63.13
Sep 28, 2026	60.39	61.92	63.55
Sep 25, 2026	61.11	62.65	64.01
Sep 24, 2026	62.20	63.71	65.11
Sep 23, 2026	62.52	63.99	65.42
Sep 22, 2026	60.48	61.87	63.34
Sep 21, 2026	60.59	62.18	63.70
Sep 18, 2026	61.50	62.91	64.34

TVTX shares fell -3.06% in Friday, September 18, 2026's trading session, dropping from a previous close of $64.74 to move at $62.76. The stock demonstrated notable intraday movement (see TVTX's key stats for a full breakdown), fluctuating between $62.50 and $64.89, a +3.82% trading range. While recent weeks have seen some volatility, TVTX has managed to secure a -3.86% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 2.23M shares changing hands, 849.9K more than the previous session. This amounted to $140.24M in total market activity.

Will TVTX Continue Its Upward Trend?

According to analyst ratings and projections for TVTX, Travere Therapeutics, Inc. shares are anticipated to increase by +3.45%, potentially reaching $65.00 per share by October 1, 2026. Short-term technical indicators currently suggest a neutral sentiment for TVTX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the TVTX stock forecast, now is a good time to buy TVTX stock because its current trading price is -1.09% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on TVTX covering social and institutional perspectives.

TVTX Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into TVTX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 40.23% to 49.76%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 56.53%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 57.84%, maintains a neutral outlook for the long term. Insights into TVTX's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Travere Therapeutics Short-Term Forecasts

TVTX Forecast For Next 5 Days

Our algorithm anticipates Travere Therapeutics (TVTX) stock could hit $64.64 by Sep 25, 2026. This represents a +2.99% fall from today's price, following a -18.06% change over the past five days.

TVTX Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Travere Therapeutics, Inc. (TVTX) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $64.72, which would mean a +3.12% increase from the current price of $62.76. Projections for this period range from a high of $71.14 to a low of $59.07.

TVTX Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Travere Therapeutics's price over the next three months point to a rise. TVTX stock is expected to peak at $73.06 on Nov 11, 2026 after potentially dipping to $59.34 on Sep 21, 2026. On average, TVTX is likely to trade around $66.57 in the coming 90 days.

Travere Therapeutics Stock Forecast 2025

Based on our predictive models, Travere Therapeutics (TVTX) is expected to trade between $59.34 and $73.40 throughout 2026. This would result in an average price of $66.90, potentially offering investors a +6.60% return from current levels.

Travere Therapeutics, Inc. Monthly Forecast 2026–2027

September 2026

According to our latest forecast models, Travere Therapeutics, Inc. (TVTX) is positioned to show a strong performance in September 2026. The price is predicted to move between $59.34 and $66.84, settling at an average of $62.86. This could translate to a +0.16% gain.

October 2026

Based on current market signals, Travere Therapeutics, Inc. is projected to trend october 2026. We forecast a trading range from $61.14 to $70.29, with a likely average price of $65.74. Investors could expect a potential return of +4.75%.

November 2026

Our predictive algorithms indicate Travere Therapeutics, Inc. stock may see a shift in November 2026. The expected range spans $64.08–$73.06, with an average target of $67.88. This represents a positive outlook and a possible gain of +8.16%.

December 2026

Analyzing established trends, Travere Therapeutics, Inc. looks set to move in December 2026. Projections place the stock between $64.09 and $73.40, averaging around $68.70. This suggests a +9.46% gain from current levels.

January 2027

Market indicators suggest Travere Therapeutics, Inc. could experience notable changes during January 2027. Prices could fluctuate within $64.67 to $73.87, with a midpoint forecast of $69.31. The stock might deliver a +10.44% gain.

February 2027

Forecasting for February 2027, models estimate that Travere Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $64.61 and $74.63, averaging $69.35. This signals a positive trajectory with potential returns around +10.50%.

March 2027

According to our latest forecast models, Travere Therapeutics, Inc. (TVTX) is positioned to show a strong performance in March 2027. The price is predicted to move between $65.85 and $76.10, settling at an average of $71.46. This could translate to a +13.86% gain.

April 2027

Based on current market signals, Travere Therapeutics, Inc. is projected to trend april 2027. We forecast a trading range from $69.45 to $77.54, with a likely average price of $73.44. Investors could expect a potential return of +17.02%.

May 2027

Our predictive algorithms indicate Travere Therapeutics, Inc. stock may see a shift in May 2027. The expected range spans $70.32–$78.70, with an average target of $74.44. This represents a positive outlook and a possible gain of +18.61%.

June 2027

Analyzing established trends, Travere Therapeutics, Inc. looks set to move in June 2027. Projections place the stock between $70.83 and $79.59, averaging around $74.95. This suggests a +19.42% gain from current levels.

July 2027

Market indicators suggest Travere Therapeutics, Inc. could experience notable changes during July 2027. Prices could fluctuate within $70.31 to $80.06, with a midpoint forecast of $75.03. The stock might deliver a +19.55% gain.

August 2027

Forecasting for August 2027, models estimate that Travere Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $72.08 and $82.04, averaging $77.47. This signals a positive trajectory with potential returns around +23.44%.

September 2027

According to our latest forecast models, Travere Therapeutics, Inc. (TVTX) is positioned to show a strong performance in September 2027. The price is predicted to move between $75.25 and $82.39, settling at an average of $79.05. This could translate to a +25.96% gain.

TVTX's history of dividends and stock splits also plays a role in long-term investor confidence.